WallStreetZenWallStreetZen

NYSEMKT: CYBN
Cybin Inc Stock

$0.63+0.08 (+14.55%)
Updated Sep 25, 2023
CYBN Price
$0.63
Fair Value Price
N/A
Market Cap
$134.59M
52 Week Low
$0.21
52 Week High
$0.66
P/E
-3.2x
P/B
4.48x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$36.80M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.15
Operating Cash Flow
-$35M
Beta
0.94
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CYBN Overview

Cybin Inc. is a biotechnology company focused on researching and progressing psychedelic therapeutics for psychiatric disorders. It has also developed EMBARK, psychedelic-assisted psychotherapy. The company's development pipeline includes CYB003, CYB004, and CYB005, among others. The company was founded in 2019 and is headquartered in Toronto, Canada.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CYBN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CYBN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CYBN is good value based on its book value relative to its share price (4.48x), compared to the US Biotechnology industry average (5.09x)
P/B vs Industry Valuation
CYBN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CYBN due diligence checks available for Premium users.

Be the first to know about important CYBN news, forecast changes, insider trades & much more!

Valuation

CYBN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.2x
Industry
12.93x
Market
14.28x

CYBN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.48x
Industry
5.09x
CYBN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CYBN's financial health

Profit margin

Revenue
$0.0
Net Income
-$10.9M
Profit Margin
0%
CYBN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$34.4M
Liabilities
$4.5M
Debt to equity
0.15
CYBN's short-term assets ($11.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CYBN's short-term assets ($11.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CYBN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$8.0M
Investing
-$48.9k
Financing
$2.6M
CYBN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CYBN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CYBN$134.59M+14.55%-3.20x4.48x
LBPH$134.89M+4.63%-2.30x2.32x
DSGN$132.97M-1.04%-1.77x0.45x
ANNX$132.57M+3.32%-1.32x0.72x
ALT$132.24M-3.83%-1.53x0.79x

Cybin Stock FAQ

What is Cybin's quote symbol?

(NYSEMKT: CYBN) Cybin trades on the NYSEMKT under the ticker symbol CYBN. Cybin stock quotes can also be displayed as NYSEMKT: CYBN.

If you're new to stock investing, here's how to buy Cybin stock.

What is the 52 week high and low for Cybin (NYSEMKT: CYBN)?

(NYSEMKT: CYBN) Cybin's 52-week high was $0.66, and its 52-week low was $0.21. It is currently -3.82% from its 52-week high and 200% from its 52-week low.

How much is Cybin stock worth today?

(NYSEMKT: CYBN) Cybin currently has 213,631,267 outstanding shares. With Cybin stock trading at $0.63 per share, the total value of Cybin stock (market capitalization) is $134.59M.

Cybin stock was originally listed at a price of $2.76 in Aug 5, 2021. If you had invested in Cybin stock at $2.76, your return over the last 2 years would have been -77.17%, for an annualized return of -52.22% (not including any dividends or dividend reinvestments).

How much is Cybin's stock price per share?

(NYSEMKT: CYBN) Cybin stock price per share is $0.63 today (as of Sep 25, 2023).

What is Cybin's Market Cap?

(NYSEMKT: CYBN) Cybin's market cap is $134.59M, as of Sep 26, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cybin's market cap is calculated by multiplying CYBN's current stock price of $0.63 by CYBN's total outstanding shares of 213,631,267.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.